Senior insider sale
EVP and CFO at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$3.23M
7K shares
What this filing means
WAGNER CHARLES F JR plans to sell 7K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $3.23M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/3/2025ACC: 0001959173-25-007469
Officer· EVP and CFO
Since Apr 2019
7K
Shares to sell
$3.23M
Approx. market value
7K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Restricted Stock Vesting
Compensation
2/20/2024
2.78KRestricted Stock Vesting
Compensation
2/17/2024
534.00Restricted Stock Vesting
Compensation
2/10/2024
3.69KTotal acquired7K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/20/2024 | Restricted Stock Vesting Compensation | 2.78K | — |
2/17/2024 | Restricted Stock Vesting Compensation | 534.00 | — |
2/10/2024 | Restricted Stock Vesting Compensation | 3.69K | — |
| Total | 7K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
7K
Market value
$3.23M
12/3/2025
Total
Units
7K
Value
$3.23M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/3/2025 | 7K | $3.23M | NASDAQ | Planned |
| Total | 7K | $3.23M | ||